Form 4: Prestige Consumer Healthcare CEO Acquires Shares and Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Ronald M. Lombardi, CEO of Prestige Consumer Healthcare, reports acquisition of shares and restricted stock units.

Summary

  • On May 7, 2024, Ronald M. Lombardi, the CEO of Prestige Consumer Healthcare Inc., acquired 14,298 shares of common stock at $0.00 per share.
  • Following the transaction, Lombardi directly owns 320,952 shares of Prestige Consumer Healthcare Inc.
  • Lombardi also acquired restricted stock units that vest in three equal installments on May 7, 2025, 2026, and 2027.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of insider transactions. The acquisition of shares by the CEO is a mildly positive signal.

Positives

  • The CEO's acquisition of shares could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The restricted stock units vest over the next three years, indicating a long-term incentive for the CEO.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders.

Stakeholder Impact

  • The CEO's stock acquisition could positively influence shareholder sentiment.

Key Dates

DateDescription
05/07/2024Date of transaction: Acquisition of shares and restricted stock units.
05/07/2025First vesting date for restricted stock units.
05/07/2026Second vesting date for restricted stock units.
05/07/2027Third vesting date for restricted stock units.
05/09/2024Date of signature.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.